Board of Directors

Managing Partner, Epidarex Capital

Sinclair has over 20 years of experience successfully building early-stage life science companies and delivering competitive returns to international investors. Sinclair is the Co-Founder and Managing Partner of four Epidarex Funds.  He has venture investing experience in North America, Europe and East Asia and has built an international network of blue-chip investors from both the public and private sectors. Sinclair is a Director of Epidarex Management Ltd, Epidarex Capital Management LLC and he serves on the Boards of Apellis Pharmaceuticals, Inc., Clyde Biosciences Ltd. and Lario Therapeutics Ltd.

Sinclair received his M.B.A. from Columbia Business School where he was the R.C. Kopf British-American Fellow in International Business. He holds an M.A. with Honours in Political Economy from the University of Glasgow and an M.A. in International Relations from the Maxwell School of Citizenship and Public Affairs at Syracuse University. Sinclair is a St. Andrew’s Society of New York Scholar. Earlier in his career, he was a political economist with the Centre for Strategic and International Studies in Washington, D.C.